The Commonwealth Fund

International Lessons on Pricing and Financing High-Cost Medicines: Policy Options for the United States

Novel medicines hold promise for patients, but rising costs pose affordability and equity challenges for health systems ...
The Commonwealth FundOpinion

Beyond “Most Favored Nation” Drug Pricing: What the U.S. Can Learn from Other Countries

The renewed debate over Most Favored Nation (MFN) drug pricing in the United States reflects a legitimate frustration: ...
The Commonwealth Fund

Some States Blunted the Impact of Lost Federal Marketplace Subsidies, But Efforts Will Be Hard to Sustain

Initial numbers show marketplace sign-ups down by more than 1 million people nationwide in 2026, with enrollment expected to ...
The Commonwealth Fund

Sharing a Workplace: How Health Systems Make Artificial Intelligence Useful to Clinicians

This issue of Transforming Care looks at how employees of health care systems are working to make AI useful while also ...
Commonwealth Fund

Health Care Quality-Spending Interactive

The U.S. spends far more on health care than other wealthy nations, but that investment does not achieve better quality of care or improved health outcomes . Furthermore, both spending and quality ...
Commonwealth Fund

Selected Health and System Statistics

Explore comparative data on key health system characteristics and performance indicators such as overall health care spending, hospital spending and utilization, health care access, and more.
Commonwealth Fund

Harkness Fellowships in Health Care Policy and Practice

The Commonwealth Fund's Harkness Fellowships provide a unique opportunity for individuals who are committed to advancing health care policy and practice to spend a year in the United States conducting ...